| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/06/2005 | CN1604893A Cyclic amine compounds |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195736C Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/05/2005 | US6875888 Method for the production of esters of unsaturated carboxylic acids |
| 04/05/2005 | US6875870 Discoloration inhibition, colorfastness for candle wax; polymers |
| 04/05/2005 | US6875831 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875777 Compounds |
| 04/05/2005 | US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | US6875759 Anticancer agents; analgesics |
| 04/05/2005 | CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 04/05/2005 | CA2245686C In situ block copolymer formation during polymerization of a vinyl aromatic monomer |
| 03/31/2005 | WO2005028467A1 Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
| 03/31/2005 | WO2005028440A1 Novel gamma secretase inhibitors |
| 03/31/2005 | WO2005028439A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028438A1 Novel piperidine derivative |
| 03/31/2005 | WO2005028436A2 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2005028425A2 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 03/31/2005 | WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 03/31/2005 | WO2005005345A3 Use of functionalized onium salts as a soluble support for organic synthesis |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 03/31/2005 | US20050070520 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2808646A1 Thalidomide analogs |
| 03/31/2005 | CA2551037A1 Novel piperidine derivative |
| 03/31/2005 | CA2539842A1 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 03/31/2005 | CA2538960A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | CA2538864A1 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | CA2538590A1 Novel gamma secretase inhibitors |
| 03/31/2005 | CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/30/2005 | EP1517894A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 03/30/2005 | EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators |
| 03/30/2005 | EP1360184B1 Piperidine derivatives as neurokinin 1 antagonists |
| 03/30/2005 | EP1087765B1 Use of optically pure (-) norcisapride in the treatment of irritable bowel syndrome |
| 03/30/2005 | EP1047674B1 Process for production of donepezil derivatives |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872832 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/29/2005 | US6872735 LFA-1 antagonist compounds |
| 03/29/2005 | US6872716 Sexual diosrders; schizophrenia; drug abuse; eating disorders anxiolytic agents |
| 03/24/2005 | WO2005026171A1 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d¸6,5-d']dipyrimidyne and 10-aza-analogue thereof |
| 03/24/2005 | WO2005025568A1 Ophthalmic compositions for treating ocular hypertension |
| 03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
| 03/24/2005 | WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/24/2005 | WO2004087074A3 Process for making substituted pyrazoles |
| 03/24/2005 | WO2004080583A3 PROCESS FOR THE PREPARATION OF threo-METHYLPHENIDATE HYDROCHLORIDE |
| 03/24/2005 | WO2004064730A3 Compounds, compositions and methods |
| 03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 03/24/2005 | US20050065346 anticoagulants; thrombosis; factor x inhibitor |
| 03/24/2005 | US20050065345 pipecolic acid or an acid salt reacted with an amine (i,e 2,6-dimethylaniline) in an inert solvent in presence of a condensing agent such as dicyclohexylcarbodiimide, 1-ethyl-2-(2-dimethylaminopropyl)carbodiimide, methanesulfonyl chloride or phosphoryl chloride to form pipecolic acid-2,6-xylidide |
| 03/24/2005 | US20050065339 Amino-alkyl derivatives |
| 03/24/2005 | US20050065211 Ester derivatives |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065161 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 03/24/2005 | US20050065144 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065142 Antidiabetic agents; therapy for insulin resistance |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065139 Antidiabetic agents; controlling carbohydrate metabolism |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2539049A1 Quinazoline derivatives |
| 03/24/2005 | CA2538410A1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
| 03/24/2005 | CA2537430A1 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1516872A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 03/23/2005 | EP1515969A1 Spiroindolinepiperidine derivatives |
| 03/23/2005 | EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 03/23/2005 | EP1515950A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
| 03/23/2005 | EP1515945A2 Method for making aryl hydrazines and substituted indoles |
| 03/23/2005 | EP1280528B1 R-eliprodil for treating glaucoma |
| 03/23/2005 | CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor |
| 03/23/2005 | CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/23/2005 | CN1599721A CCR-3 receptor antagonists VII |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1597680A New method of synthesizing thalidomide and its derivative |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 03/17/2005 | WO2005023794A2 Compound libraries of 4-carboxamidopiperidine derivatives |
| 03/17/2005 | WO2005023769A1 Process for the preparation of amlodipine salts |
| 03/17/2005 | WO2005023768A1 An improved process for the preparation of pure nisoldipine |
| 03/17/2005 | WO2005023767A2 Diastereomers of 4-aryloxy-3-hydroxypiperidines |
| 03/17/2005 | WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023183A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 03/17/2005 | WO2005023182A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/17/2005 | WO2004056809A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004056808A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 03/17/2005 | US20050059825 Reacting esters of 2,5-bis(2,2,2-trifluoroethoxy)-benzoic acid with primary amino group of 2-(aminomethyl)piperidine; high yield and purity; starting material has low toxicity; arrhythmia |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |